Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Robot takes aim at bladder tumors with precision

NCT ID NCT06940648

Disease control Sponsor: Virtuoso Surgical, Inc. Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only This study
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 30, 2026 · Updated 2 times

Summary

This study tests a robotic-assisted surgery tool to remove bladder lesions. About 30 adults with small bladder tumors will undergo the procedure. The goal is to see if the robot helps remove the tumor in one piece with healthy tissue around it, which may improve diagnosis and reduce complications.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 30 people

The number the study aims to enrol. It can still change while the study runs.

Started

Apr 2025

Expected to finish

Sep 2026

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

22 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. The subject is 22 years or older. 2. The subject is eligible and fit for transurethral bladder lesion removal and/or biopsy and has an appropriate indication to go through this surgery. 3. The subject is willing and able to provide written informed consent and comply with the study protocol. 4. The subject can undergo general anesthesia per anesthesiologist assessment. 5. The subject's planned aggregated bladder lesion(s) excision specimens are smaller than 3 cm. Exclusion Criteria: 1. The subject has acute untreated urinary tract infection or urosepsis. 2. The subject has a documented nickel allergy or nickel sensitivity. 3. The subject is confirmed to be or suspected to be pregnant. 4. The subject is receiving anticoagulants and is unable or not willing to cease the medication for the investigational procedure. 5. The subject belongs to a vulnerable group (prisoner, etc.) 6. The subject has a urethral abnormality, implant, or previous surgery which would conflict with the procedure. 7. The subject has undergone a transurethral bladder resection procedure in the past 6 months. 8. The subject has a history of radiation treatment within the pelvis. 9. Bladder tumor base maximal dimension is greater than 3 cm. 10. Bladder tumor detected during intravesical therapy. 11. Previous histological diagnosis different than non-muscle invasive bladder cancer. 12. Presence or prior history of upper urinary tract malignancy. 13. Eastern Cooperative Oncology Group performance status greater than or equal to 3. 14. American Society of Anesthesiologists physical status classification of IV or above. 15. History of bleeding disorder, coagulation abnormality, or use of anticoagulants. 16. The presence of other active malignancy. 17. Life expectancy \<1 yr.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Bladder neoplasm are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

urinary bladder neoplasm Urinary Bladder Neoplasms

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Bladder neoplasm

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    The full official record for this study. This one lists no contact details, but it is the first place any would appear.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Prince of Wales Hospital, Chinese University of Hong Kong

    Hong Kong, Hong Kong, Hong Kong

More trials for these conditions

Other studies related to the condition(s) this trial covers.